CSBR.US Champions Oncology Inc

Healthcare Life Sciences Tools & Services USA Stocks
4.71 USD
Close of Nov 13, 2026
4.52 8.31
Market cap
USD 65.5M
P/E
-
P/B
16.63x
ROE
-43.8%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jul 2026.

Is CSBR.US undervalued?

Graham number

The Graham number of Champions Oncology Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Champions Oncology Inc fundamental analysis

No fundamental analysis for Champions Oncology Inc yet.

Champions Oncology Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Champions Oncology Inc

Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice through TumorGraft Technology Platform. It also offers translational oncology solutions that utilizes its technology platform to provide research services that assist in the drug development process of pharmaceut…

Full company profile